May cause drowsiness or dizziness
J Physiol Paris 93:479485 Sikiric P, Seiwerth S, Brcic L, Blagaic AB, Zoricic I, Sever M, Klicek R, Radic B, Keller N, Sipos K et al (2006) Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia)
doi: 10.1016/j.mri.2008.05.014
R Phase I creates reactive intermediates through oxidation, reduction, and hydrolysis (mostly via cytochrome P450 enzymes)
AOD-9604 Advanced Obesity Drug 9604 is a modified fragment of human growth hormone (HGH), specifically amino acids 176-191 from the C-terminal end
Topical GHK-Cu is a local intervention: the copper tripeptide is placed directly against the tissue it is meant to influence, and only a limited fraction reaches deeper layers or the systemic circulation